Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2019-05-07, Stock:LLY, The news for the past five days is as follows:
2019-04-30: NEWS1: Eli Lilly misses estimates for top-selling diabetes drug Trulicity, shares slip.NEWS2: Alphabet and Eli Lilly tumble while WageWorks and GE jump.NEWS3: S&P 500 ekes out third straight record close; Nasdaq retreats after Google revenue miss.NEWS4: Dow Drug Giants Top First-Quarter Estimates; But Another Pharma Dives.NEWS5: What's Behind Eli Lilly's Mixed Q1 Results.NEWS6: What's Behind Eli Lilly's Mixed Q1 Results.NEWS7: Notable Tuesday Option Activity: INTU, AKAM, LLY.NEWS8: Notable Tuesday Option Activity: INTU, AKAM, LLY.NEWS9: What&apos;s Behind Eli Lilly&apos;s Mixed Q1 Results.NEWS10: Lilly (LLY) Down Despite Q1 Earnings Beat on Sales View Cut.NEWS11: Lilly (LLY) Down Despite Q1 Earnings Beat on Sales View Cut.NEWS12: 3 Tech Stocks for Growth Investors to Buy Right Now.NEWS13: Pfizer, Merck beat earnings expectations, Eli Lilly misses on revenue.NEWS14: Incyte (INCY) Q1 Earnings & Revenues Beat Estimates, Up Y/Y.NEWS15: Incyte (INCY) Q1 Earnings & Revenues Beat Estimates, Up Y/Y.NEWS16: Stocks slide as Google revenue miss weighs on tech shares.NEWS17: Lilly (LLY) Down Despite Q1 Earnings Beat on Sales View Cut.NEWS18: Eli Lilly slashes guidance in face of pricing pressures and growing generic competition.NEWS19: Will Gilead Stock Get A Needed Boost From This Week’s Earnings Report?.NEWS20: Will Gilead Stock Get A Needed Boost From This Week’s Earnings Report?.NEWS21: Big Pharma Puts the Price Squeeze on Itself.NEWS22: Incyte (INCY) Q1 Earnings & Revenues Beat Estimates, Up Y/Y.NEWS23: Fed and tech stocks could crack the market rally, warns Wall Street strategist.NEWS24: Health Care Sector Update for 04/30/2019: LLY, PFE, NVS, JNJ, ABTX, MRK, AMGN.NEWS25: Health Care Sector Update for 04/30/2019: LLY, PFE, NVS, JNJ, ABTX, MRK, AMGN.NEWS26: Eli Lilly misses estimates for top-selling diabetes drug Trulicity, shares slip.NEWS27: Stocks making the biggest moves premarket: Alphabet, General Electric, MGM Resorts & more.NEWS28: Stocks making the biggest moves premarket: Alphabet, General Electric, MGM Resorts & more.NEWS29: See what the IHS Markit Score report has to say about Eli Lilly and Co..NEWS30: Pfizer, Merck Earnings Top; Eli Lilly Falls On Revenue.NEWS31: Eli Lilly Reports Better-Than-Expected Earnings but Shares Decline.NEWS32: Three major pharmaceutical companies just reported earnings — here&apos;s how they did.NEWS33: Three major pharmaceutical companies just reported earnings — here's how they did.NEWS34: Here's a breakdown of Big Pharma earnings from Merck, Pfizer, Eli Lilly.NEWS35: Pricing pressure weighs on revenue at drugmaker Eli Lilly.NEWS36: Eli Lilly's stock sinks after earnings beat but revenue comes up short, hurt by Trulicity and Alimta misses.NEWS37: Eli Lilly&apos;s stock sinks after earnings beat but revenue comes up short, hurt by Trulicity and Alimta misses.NEWS38: Will Gilead Stock Get A Needed Boost From This Week’s Earnings Report?.NEWS39: Lilly: 1Q Earnings Snapshot.NEWS40: Lilly Reports Solid First-Quarter 2019 Financial Results, Updates 2019 Guidance to Reflect Disposition of Elanco Animal Health.NEWS41: Today Is Earnings Day for Big Pharma. Here’s What to Watch..NEWS42: Stocks - Alphabet Plunges in Premarket, GE Surges, McDonald’s Soars.NEWS43: Stocks - U.S. Futures Hover Close to Highs on Mixed Data; Fed Eyed.NEWS44: Eli Lilly Earnings Beat, Revenue Misses In Q1.
2019-05-01: NEWS1: Amgen (AMGN) Q1 Earnings Top, Sales Hurt by Pricing Pressure.NEWS2: Amgen (AMGN) Q1 Earnings Top, Sales Hurt by Pricing Pressure.NEWS3: Are You Looking for a High-Growth Dividend Stock? Eli Lilly (LLY) Could Be a Great Choice.NEWS4: Are You Looking for a High-Growth Dividend Stock? Eli Lilly (LLY) Could Be a Great Choice.NEWS5: Are You Looking for a High-Growth Dividend Stock? Eli Lilly (LLY) Could Be a Great Choice.NEWS6: Amgen (AMGN) Q1 Earnings Top, Sales Hurt by Pricing Pressure.NEWS7: Eli Lilly misses on revenue in face of pricing pressures and growing generic competition.NEWS8: Eli Lilly and Company (LLY) Q1 2019 Earnings Call Transcript.NEWS9: Eli Lilly and Company (LLY) Q1 2019 Earnings Call Transcript.NEWS10: Eli Lilly and Company (LLY) Q1 2019 Earnings Call Transcript.NEWS11: Amgen Reports an Unusual Slide Backward.NEWS12: Amgen Reports an Unusual Slide Backward.
2019-05-02: NEWS1: Teva's new migraine drug helps to contain profit fall.NEWS2: United Therapeutics (UTHR) Down Despite Q1 Earnings Beat.NEWS3: United Therapeutics (UTHR) Down Despite Q1 Earnings Beat.NEWS4: United Therapeutics (UTHR) Down Despite Q1 Earnings Beat.NEWS5: Lilly to Present New Data at AAN 2019 on Emgality® (galcanezumab-gnlm) and Lasmiditan Reinforcing Breadth of Headache Disorders Portfolio.
2019-05-03: NEWS1: Migraine drugs cause pain for investors.NEWS2: Flippin Bruce & Porter Inc Buys Norfolk Southern Corp, Sells Eli Lilly and Co.NEWS3: Novo Nordisk (NVO) Q1 Earnings and Revenues Miss Estimates.NEWS4: Novo Nordisk (NVO) Q1 Earnings and Revenues Miss Estimates.NEWS5: Notable ETF Inflow Detected - VTI, CMCSA, MCD, LLY.NEWS6: Notable ETF Inflow Detected - VTI, CMCSA, MCD, LLY.NEWS7: Novo Nordisk (NVO) Q1 Earnings and Revenues Miss Estimates.NEWS8: Pharma Stock Roundup: MRK, LLY, PFE Report Q1 Earnings, SNY, ABBV  Drugs Get EU Nod.NEWS9: Pharma Stock Roundup: MRK, LLY, PFE Report Q1 Earnings, SNY, ABBV  Drugs Get EU Nod.NEWS10: Teva (TEVA) Q1 Earnings Beat, Copaxone Drags Sales Down.NEWS11: Teva (TEVA) Q1 Earnings Beat, Copaxone Drags Sales Down.NEWS12: Teva (TEVA) Q1 Earnings Beat, Copaxone Drags Sales Down.NEWS13: Pharma Stock Roundup: MRK, LLY, PFE Report Q1 Earnings, SNY, ABBV  Drugs Get EU Nod.
2019-05-06: NEWS1: Daily Dividend Report: LLY, CSX, KLAC, TFX, R.NEWS2: Daily Dividend Report: LLY, CSX, KLAC, TFX, R.NEWS3: Lilly Declares Second-Quarter 2019 Dividend.NEWS4: AAN 2019: Pooled Analyses of Two Emgality® (galcanezumab-gnlm) Phase 3 Studies Show Reduction in Monthly Migraine Headache Days in Low- and High-Frequency Episodic Migraine Subgroups.NEWS5: Edited Transcript of LLY earnings conference call or presentation 30-Apr-19 1:00pm GMT.

Answer: Decrease